These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33654571)

  • 1. Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study.
    Haq KT; Cao J; Tereshchenko LG
    J Innov Card Rhythm Manag; 2021 Feb; 12(2):4395-4408. PubMed ID: 33654571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vectorcardiographic determinants of cardiac memory during normal ventricular activation and continuous ventricular pacing.
    Shvilkin A; Bojovic B; Vajdic B; Gussak I; Zimetbaum P; Josephson ME
    Heart Rhythm; 2009 Jul; 6(7):943-8. PubMed ID: 19560083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interruption of Pacing Following Nonsustained Ventricular Tachycardia in an AAI Programmed Implantable Cardioverter Defibrillator.
    Egan P; Wilkoff BL; Tchou P
    Pacing Clin Electrophysiol; 2015 Sep; 38(9):1082-90. PubMed ID: 26010870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients.
    Smit MD; Van Dessel PF; Nieuwland W; Wiesfeld AC; Tan ES; Anthonio RL; Van Erven L; Van Veldhuisen DJ; Van Gelder IC
    Heart Rhythm; 2006 Dec; 3(12):1397-403. PubMed ID: 17161779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reverse mode switch algorithm: how well does it work?
    Akerström F; Arias MA; Pachón M; Puchol A; Jiménez-López J; Rodríguez-Padial L
    Heart Rhythm; 2013 Aug; 10(8):1146-52. PubMed ID: 23732226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
    Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A;
    JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications for dual-chamber (DDD) pacing in implantable cardioverter-defibrillator patients.
    Santini M; Ansalone G; Auriti A; Magris B; Pandozi C; Altamura G
    Am J Cardiol; 1996 Sep; 78(5A):116-8. PubMed ID: 8820847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do implantable cardioverter defibrillators improve survival in patients with severe left ventricular systolic dysfunction after coronary artery bypass graft surgery?
    Fazal IA; Bates MG; Matthews IG; Turley AJ
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1010-6. PubMed ID: 21398652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
    J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Spatial Ventricular Gradient Is Associated With Inducibility of Ventricular Arrhythmias During Electrophysiology Study.
    Isaza N; Stabenau HF; Kramer DB; Sau A; Tung P; Maher TR; Locke AH; Zimetbaum P; d'Avila A; Peters NS; Tereshchenko LG; Ng FS; Buxton AE; Waks JW
    Heart Rhythm; 2024 May; ():. PubMed ID: 38718942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized pilot study of a new atrial-based minimal ventricular pacing mode in dual-chamber implantable cardioverter-defibrillators.
    Sweeney MO; Shea JB; Fox V; Adler S; Nelson L; Mullen TJ; Belk P; Casavant D; Sheldon T
    Heart Rhythm; 2004 Jul; 1(2):160-7. PubMed ID: 15851147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.
    Kloppe A; Proclemer A; Arenal A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
    Circulation; 2014 Jul; 130(4):308-14. PubMed ID: 24838360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of sinus tachycardia from ventricular tachycardia with 1:1 ventriculoatrial conduction in dual chamber implantable cardioverter defibrillators: feasibility of a criterion based on the atrioventricular interval.
    LeCarpentier GL; Baga JJ; Yang H; Steinman RT; Meissner MD; Lehmann MH
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 1):1818-31. PubMed ID: 7838794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trials.
    Katritsis DG; Siontis KC; Bigger JT; Kadish AH; Steinman R; Zareba W; Siontis GC; Bardy GH; Ioannidis JP
    Heart Rhythm; 2013 Feb; 10(2):200-6. PubMed ID: 23107652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II.
    Berenbom LD; Weiford BC; Vacek JL; Emert MP; Hall WJ; Andrews ML; McNitt S; Zareba W; Moss AJ
    Ann Noninvasive Electrocardiol; 2005 Oct; 10(4):429-35. PubMed ID: 16255753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value and temporal behavior of the planar QRS-T angle in patients with nonischemic cardiomyopathy.
    Pavri BB; Hillis MB; Subacius H; Brumberg GE; Schaechter A; Levine JH; Kadish A;
    Circulation; 2008 Jun; 117(25):3181-6. PubMed ID: 18574059
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.